199 related articles for article (PubMed ID: 28993957)
1. Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism.
Bucciol G; Delafontaine S; Segers H; Bossuyt X; Hershfield MS; Moens L; Meyts I
J Clin Immunol; 2017 Nov; 37(8):746-750. PubMed ID: 28993957
[No Abstract] [Full Text] [Related]
2. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
Hashem H; Kumar AR; Müller I; Babor F; Bredius R; Dalal J; Hsu AP; Holland SM; Hickstein DD; Jolles S; Krance R; Sasa G; Taskinen M; Koskenvuo M; Saarela J; van Montfrans J; Wilson K; Bosch B; Moens L; Hershfield M; Meyts I;
Blood; 2017 Dec; 130(24):2682-2688. PubMed ID: 28974505
[TBL] [Abstract][Full Text] [Related]
3. Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Moens L; Hershfield M; Arts K; Aksentijevich I; Meyts I
Immunol Rev; 2019 Jan; 287(1):62-72. PubMed ID: 30565235
[TBL] [Abstract][Full Text] [Related]
4. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
5. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation.
Barzaghi F; Minniti F; Mauro M; Bortoli M; Balter R; Bonetti E; Zaccaron A; Vitale V; Omrani M; Zoccolillo M; Brigida I; Cicalese MP; Degano M; Hershfield MS; Aiuti A; Bondarenko AV; Chinello M; Cesaro S
Front Immunol; 2018; 9():2767. PubMed ID: 30692987
[TBL] [Abstract][Full Text] [Related]
6. Monogenic polyarteritis: the lesson of ADA2 deficiency.
Caorsi R; Penco F; Schena F; Gattorno M
Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
[No Abstract] [Full Text] [Related]
8. Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations.
Saettini F; Fazio G; Corti P; Quadri M; Bugarin C; Gaipa G; Penco F; Moratto D; Chiarini M; Baronio M; Gazzurelli L; Imberti L; Paghera S; Giliani S; Cazzaniga G; Plebani A; Badolato R; Lougaris V; Gattorno M; Biondi A
Clin Immunol; 2020 Sep; 218():108525. PubMed ID: 32659374
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.
Van Montfrans JM; Hartman EA; Braun KP; Hennekam EA; Hak EA; Nederkoorn PJ; Westendorp WF; Bredius RG; Kollen WJ; Schölvinck EH; Legger GE; Meyts I; Liston A; Lichtenbelt KD; Giltay JC; Van Haaften G; De Vries Simons GM; Leavis H; Sanders CJ; Bierings MB; Nierkens S; Van Gijn ME
Rheumatology (Oxford); 2016 May; 55(5):902-10. PubMed ID: 26867732
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
[TBL] [Abstract][Full Text] [Related]
11. Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.
Schepp J; Proietti M; Frede N; Buchta M; Hübscher K; Rojas Restrepo J; Goldacker S; Warnatz K; Pachlopnik Schmid J; Duppenthaler A; Lougaris V; Uriarte I; Kelly S; Hershfield M; Grimbacher B
Arthritis Rheumatol; 2017 Aug; 69(8):1689-1700. PubMed ID: 28493328
[TBL] [Abstract][Full Text] [Related]
12. A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report.
Lucane Z; Davidsone Z; Micule I; Auzenbaha M; Kurjane N
Pediatr Rheumatol Online J; 2022 Dec; 20(1):118. PubMed ID: 36528591
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
Human A; Pagnoux C
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.
Skrabl-Baumgartner A; Plecko B; Schmidt WM; König N; Hershfield M; Gruber-Sedlmayr U; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2017 Aug; 15(1):67. PubMed ID: 28830446
[TBL] [Abstract][Full Text] [Related]
15. [Research progress in deficiency of adenosine deaminase 2].
Guo L; Lu MP
Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):520-523. PubMed ID: 32521969
[TBL] [Abstract][Full Text] [Related]
16. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
Garg N; Kasapcopur O; Foster J; Barut K; Tekin A; Kızılkılıç O; Tekin M
Eur J Pediatr; 2014 Jun; 173(6):827-30. PubMed ID: 24737293
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency.
Al-Herz W; Chu JI; van der Spek J; Raghupathy R; Massaad MJ; Keles S; Biggs CM; Cockerton L; Chou J; Dbaibo G; Elisofon SA; Hanna-Wakim R; Kim HB; Lehmann LE; McDonald DR; Notarangelo LD; Veys P; Chatila TA; Geha RS; Gaspar HB; Pai SY
J Allergy Clin Immunol; 2016 Sep; 138(3):852-859.e3. PubMed ID: 27130861
[TBL] [Abstract][Full Text] [Related]
18. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
[TBL] [Abstract][Full Text] [Related]
19. ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype.
Ferriani MPL; Valera ET; de Sousa GR; Sandrin-Garcia P; de Moura RR; Hershfield MS; de Carvalho LM
Rheumatology (Oxford); 2021 Jul; 60(7):e237-e239. PubMed ID: 33493352
[No Abstract] [Full Text] [Related]
20. ADA2 regulates inflammation and hematopoietic stem cell emergence via the A
Brix A; Belleri L; Pezzotta A; Pettinato E; Mazzola M; Zoccolillo M; Marozzi A; Monteiro R; Del Bene F; Mortellaro A; Pistocchi A
Commun Biol; 2024 May; 7(1):615. PubMed ID: 38777862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
